Astec LifeSciences Limited (NSE:ASTEC)
India · Delayed Price · Currency is INR 650.50
+23.50 (3.75%)
Jul 31, 2026, 3:29 PM IST
Astec LifeSciences Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 4,408 | 4,481 | 3,813 | 4,586 | 6,285 | 6,769 |
Revenue Growth | 9.39% | 17.53% | -16.86% | -27.03% | -7.15% | 21.16% |
Gross Profit Gross Profit Growth | 1,538 | 1,399 | 757.2 | 1,338 | 2,216 | 2,849 |
Operating Income Operating Income Growth | -384.15 | -493.82 | -1,099 | -415.94 | 434.56 | 1,203 |
Net Income Net Income Growth | -665.97 | -809.18 | -1,348 | -469.3 | 255.65 | 898.59 |
Earnings Per Share EPS Growth | -30.16 | -37.79 | -68.71 | -23.93 | 13.04 | 45.85 |
EPS Growth | - | - | - | - | -71.56% | 38.06% |
| Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
India India Growth | 1,695 | 1,196 | 1,301 | 2,458 | 2,860 |
outside India outside India Growth | 2,762 | 2,586 | 3,276 | 3,823 | 3,906 |
Total Total Growth | 4,457 | 3,781 | 4,577 | 6,282 | 6,766 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 100.49 | 100.49 | 5.75 | 4.72 | 4.73 | 5.55 |
Total Debt Total Debt Growth | 4,489 | 4,489 | 5,545 | 4,939 | 3,412 | 2,794 |
Net Cash (Debt) Net Cash Growth | -4,389 | -4,389 | -5,540 | -4,934 | -3,407 | -2,788 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -198.77 | -204.97 | -282.47 | -251.61 | -173.77 | -142.26 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | -807.08 | -83.99 | 102.21 | 746.56 | 236.04 |
Capital Expenditures CapEx Growth | - | -55.36 | -218.22 | -1,355 | -1,173 | -1,040 |
Free Cash Flow Free Cash Flow Growth | - | -862.44 | -302.21 | -1,253 | -426.03 | -803.74 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 34.89% | 31.21% | 19.86% | 29.17% | 35.26% | 42.09% |
Operating Margin | -8.71% | -11.02% | -28.83% | -9.07% | 6.91% | 17.78% |
Pretax Margin | -15.13% | -18.07% | -36.98% | -13.46% | 5.56% | 17.89% |
Profit Margin | -15.11% | -18.06% | -35.34% | -10.23% | 4.07% | 13.28% |
FCF Margin | - | -19.25% | -7.93% | -27.32% | -6.78% | -11.87% |
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|
| Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 1.500 | 1.500 | 1.500 |
Dividend Per Share Growth | 0% | 0% | 0% |
Dividend Yield | 0.14% | 0.11% | 0.09% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 1, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | - | - | - | - | 106.22 | 38.27 |
Forward PE | 56.13 | 91.24 | 58.44 | 65.84 | 31.83 | 37.10 |
PS Ratio | 3.31 | 2.69 | 3.47 | 4.56 | 4.32 | 5.08 |